124 related articles for article (PubMed ID: 24335716)
1. Taxanes as radiosensitizers.
Golden EB; Formenti SC; Schiff PB
Anticancer Drugs; 2014 May; 25(5):502-11. PubMed ID: 24335716
[TBL] [Abstract][Full Text] [Related]
2. Combination of taxanes with radiation: preclinical studies.
Milas L; Milas MM; Mason KA
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):12-26. PubMed ID: 10210536
[TBL] [Abstract][Full Text] [Related]
3. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
4. Taxanes in combined-modality therapy for solid tumors.
Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis as a predictor of paclitaxel-induced radiosensitization in human tumor cell lines.
Kurdoglu B; Cheong N; Guan J; Corn BW; Curran WJ; Iliakis G
Clin Cancer Res; 1999 Sep; 5(9):2580-7. PubMed ID: 10499636
[TBL] [Abstract][Full Text] [Related]
6. New radiosensitizing regimens, drugs, prodrugs, and candidates.
Vallerga AK; Zarling DA; Kinsella TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
[TBL] [Abstract][Full Text] [Related]
7. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
Kimple RJ
Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-directed drug strategies to target the tumor microenvironment.
Hay MP; Hicks KO; Wang J
Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
Gorodetsky R; Levdansky L; Ringel I; Vexler A
Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
[TBL] [Abstract][Full Text] [Related]
11. Principles of chemoradiation: theoretical and practical considerations.
Herscher LL; Cook JA; Pacelli R; Pass HI; Russo A; Mitchell JB
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):11-22. PubMed ID: 10550823
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitizers: rationale and potential.
Brown JM
Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
[TBL] [Abstract][Full Text] [Related]
13. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines.
Chen Y; Pandya K; Keng PC; Johnstone D; Li J; Lee YJ; Smudzin T; Okunieff P
Clin Cancer Res; 2003 Mar; 9(3):969-75. PubMed ID: 12631594
[TBL] [Abstract][Full Text] [Related]
16. New and emerging radiosensitizers and radioprotectors.
Spalding AC; Lawrence TS
Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
Sartor CI
Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
[TBL] [Abstract][Full Text] [Related]
18. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).
Huang SM; Li J; Armstrong EA; Harari PM
Cancer Res; 2002 Aug; 62(15):4300-6. PubMed ID: 12154033
[TBL] [Abstract][Full Text] [Related]
19. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
20. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
